triazoles has been researched along with Hypertriglyceridemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Anabuki, J; Fukuda-Tsuru, S; Ishii, S; Yoshida, K | 1 |
| Berthiaume, M; Cianflone, K; Deshaies, Y; Festuccia, WT; Joanisse, DR; Laplante, M; Olivecrona, G; Thieringer, R; Turcotte, LP | 1 |
2 other study(ies) available for triazoles and Hypertriglyceridemia
| Article | Year |
|---|---|
A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations.
Topics: Adamantane; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Nitriles; Pyrazines; Pyrazoles; Pyrrolidines; Rats; Rats, Wistar; Rats, Zucker; Sitagliptin Phosphate; Thiazolidines; Triazoles; Vildagliptin | 2012 |
11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue, Brown; Animals; Enzyme Inhibitors; Heart; Hypertriglyceridemia; Lipid Metabolism; Lipoproteins, VLDL; Liver; Male; Muscle, Skeletal; Myocardium; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Triazoles; Triglycerides | 2007 |